Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.

AIDS (London, England) - 3 May 2002

Aleman Soo, Söderbärg Karin, Visco-Comandini Ubaldo, Sitbon Gisela, Sönnerborg Anders

Abstract excerpt

OBJECTIVE: To study the appearance of drug-induced mutations at low viraemia in treated HIV-1-infected patients. DESIGN AND METHODS: Fourteen patients, who received their first (n = 5), second (n = 7) or third (n = 2) line antiretroviral combination therapy, developed a persistent low-grade viraemia after an initial decrease of the viral load (VL) to less than 500 copies/ml. The amount of HIV-1 RNA (n = 71) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple, Viral

Share to HIV Protease

Share to HIV Protease Inhibitors

Share to HIV Reverse Transcriptase

Share to Reverse Transcriptase Inhibitors

Share to Viremia

Source

Identifiers

PMID: 11953470
DOI: 10.1097/00002030-200205030-00010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.PMID 11953470Read ↗

Drug resistance is rarely the cause or consequence of long-term persistent low-level viraemia in HIV-1-infected patients on ART.Semantic proximity Read ↗

Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level ViremiaSemantic proximity Read ↗

Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study.Semantic proximity Read ↗

Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients.Semantic proximity Read ↗

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.Semantic proximity Read ↗

Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.Semantic proximity Read ↗

Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia.Semantic proximity Read ↗

Persistence of primary drug resistance among recently HIV-1 infected adults.Semantic proximity Read ↗

Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapy.Semantic proximity Read ↗

In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.Semantic proximity Read ↗

Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia LevelsSemantic proximity Read ↗

HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.